Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover how reductive aminocarbonylation with molybdenum carbonyl reduces raw material costs by 30-40% for (hetero)chroman amide synthesis. Scale-ready for API manufacturing.
Discover a one-step palladium-catalyzed method for benzofuran-3-carboxamide synthesis. Achieve high efficiency, broad substrate tolerance, and simplified post-processing to reduce production costs and supply chain risks.
Discover a cost-effective, high-yield synthesis of 1,5-dihydro-2H-pyrrole-2-ketone with Pd-catalyzed carbonylation. Reduce supply chain risks and accelerate API development. Contact us for custom manufacturing.
Solve chiral drug synthesis challenges with metal-free catalysis. Achieve >99% ee, mild conditions, and scalable production for pharmaceutical intermediates. Reduce costs and supply chain risks.
Solve multi-step synthesis challenges for polycyclic quinolinone derivatives with 50-70% yields. Reduce costs and supply chain risks with scalable, high-purity production.
Discover a cost-effective, high-yield method for indole ketone thioester synthesis using sulfonyl chloride as sulfur source. Eliminate catalyst poisoning risks and simplify production for pharmaceutical intermediates.
Solve high-cost N-difluoromethylation challenges with this room-temperature, metal-free method. 90% yields, broad substrate tolerance, and no special equipment needed. Scale to 100 MT/yr.
Solve high-cost deuteration challenges with 98% deuterated aldehyde yield. Our CDMO expertise in metal-free catalysis ensures scalable, pure intermediates for drug development.
Discover a novel one-step hydroxytyrosol synthesis method with 90% yield and no column chromatography. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve C-F bond synthesis challenges with 94% yield, wide substrate scope, and industrial scalability for pharma/agrochemical R&D and procurement teams.
Solve hydroxytyrosol production challenges: 95%+ purity, 90% yield, no column chromatography. Reduce costs & scale up with optimized LiAlH4 process.
Solve high production costs and low yields in diaza-bridge synthesis. Our CDMO expertise delivers 94.8% purity with 65.5% yield, eliminating column chromatography. Request COA now.
Discover how nitroarene-based amide synthesis with molybdenum carbonyl reduces costs and improves scalability for pharmaceutical intermediates. Contact us for custom synthesis.
Solve 5-trifluoromethyl imidazole synthesis challenges with our CDMO's scalable, high-yield process. Reduce costs by 30% and ensure supply chain stability for your API development.
Solve indole synthesis challenges with this nickel-catalyzed method. High yield, broad substrate tolerance, and simplified post-treatment reduce production costs for API manufacturing.
Discover metal-free β-iodonitroalkene synthesis with 80%+ yields. Eliminate oxidant risks & simplify GMP production for API intermediates.
Eliminate explosive peroxide risks in 5-trifluoromethyl-1,2,4-triazole synthesis. Our elemental sulfur-promoted method offers scalable, anhydrous-free production for pharma intermediates. Reduce costs and supply chain risks.
Discover a cost-effective, scalable synthesis method for 3-trifluoromethyl-1,2,4-triazole compounds with high yields. Ideal for pharmaceutical R&D and production.
Solve supply chain risks with this 95%+ yield synthesis method. Avoid explosive reagents, use cheap raw materials, and scale to 100MT/yr. Contact for COA/MSDS.
Solve high-cost synthesis challenges for 6-phosphorylphenanthridines. Our CDMO expertise delivers 68% yield, 40% less raw material waste, and simplified scale-up for pharma R&D and production.